ENBIO Co., Ltd. announced that it will issue series 3 Unregistered coupon nonguaranteed private convertible bond for gross proceeds of KRW 20,000,000,000 on September 10, 2021. The bonds will be issued at par. The transaction will include participation from Brain Growth Company BufferedBottomOpenTop Mezzanine Hedge Fund 2 for KRW 5,000,000,000, Brain Specialized Investment Hedge Fund 38 for KRW 1,000,000,000, Brain KOSDAQ Venture Hedge Fund 1 for KRW 1,000,000,000, Brain KOSDAQ Venture Hedge Fund 2 for KRW 1,000,000,000, A1 Pure Mezzanine Hedge Fund for KRW 200,000,000, A1 Galaxy KOSDAQ Venture Hedge Fund for KRW 400,000,000, A1 Horizon KOSDAQ Venture Hedge Fund for KRW 600,000,000, A1 Pride KOSDAQ Venture Hedge Fund for KRW 500,000,000, and A1 Active KOSDAQ Venture Hedge Fund for KRW 900,000,000. The bonds will bear zero coupon and will mature on September 14, 2026. The bonds are fully convertible into 2,014,504 common shares at a fixed conversion price of KRW 9,928 per share from September 14, 2022 to August 14, 2026. The date of subscription and expected date of payment is September 14, 2021. The transaction is approved by the board of directors of the company. All securities issued will be subject to a hold period of one year.